Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -41.72EBIT per Share
VS
Market
Sector
Industry
History
$ 9.25Close
$ 5.09 - $ 94.02 52-Week Range
Ticker Information
Ticker
CNSPCompany Name
CNS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCNS PHARMACEUTICALS INC - EBIT per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CNSP - EBITPS Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -15.44M | $ -41.72 | 1 | 370.13K |
| 3/31/2025 | $ -15.6M | $ -68.65 | 1 | 227.22K |
| 12/31/2024 | $ -14.84M | $ -465.94 | 1 | 31.85K |
| 9/30/2024 | $ -17.04M | $ -460.95 | 1 | 36.97K |
| 6/30/2024 | $ -15.96M | $ -25.41K | 1 | 628 |
| 3/31/2024 | $ -17.45M | $ -60.17K | 1 | 290 |
| 12/31/2023 | $ -18.84M | $ -149.5K | 1 | 126 |
| 9/30/2023 | $ -18.97M | $ -136.45K | 1 | 139 |
| 6/30/2023 | $ -17.87M | $ -138.49K | 1 | 129 |
| 3/31/2023 | $ -17.41M | $ -272.06K | 1 | 64 |
Key Performance Insights, Last 5 Years
- CNS PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITPS stands at $ -498.71K.
- Over the past 5 years, CNS PHARMACEUTICALS INC's average EBITPS has been $ -242.32K.
- The median EBITPS for CNS PHARMACEUTICALS INC during this period was $ -278.74K
- CNS PHARMACEUTICALS INC reached its highest EBITPS over the past 5 years at $ -41.72.
- The lowest EBITPS recorded by CNS PHARMACEUTICALS INC in the same timeframe $ -525.26K
Similar metrics to Shares WA:
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBIT per Share
[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for CNS PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -8.98M ] / (Shares WA [ 18 ] * Share Factor [ 1 ])
(=) EBITPS [ $ -498.71K ] CNSP - EBIT per Share, Last 5 years
$ -525.26K
Minimum
Dec 31, 2020
$ -41.72
Maximum
Jun 30, 2025
$ -242.32K
Average
$ -278.74K
Median
EBITPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.17 with a standard deviation of $ 3.43.
The following table provides additional summary stats:
EBITPS in the Market:
| filtered constituents | 3.79K |
|---|---|
| min | $ -9.72 |
| max | $ 10.84 |
| average | $ 1.17 |
| median | $ 0.39 |
| std | $ 3.43 |